Kontafarma China Holdings Limited (HKG:1312)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0300
-0.0010 (-3.23%)
Apr 2, 2026, 3:59 PM HKT

Kontafarma China Holdings Income Statement

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
914.71897.52809.11894.06803.27
Revenue Growth (YoY)
1.92%10.93%-9.50%11.30%-20.40%
Cost of Revenue
401.07381.36337.82387.84407.09
Gross Profit
513.64516.16471.29506.22396.18
Selling, General & Admin
552.27524.04542.49558.69456.81
Other Operating Expenses
8.3734.6320.7529.1134.33
Operating Expenses
558.53561.39563.62590.63493.88
Operating Income
-44.9-45.23-92.33-84.41-97.71
Interest Expense
-10.76-13.39-15.25-23.28-33.61
Interest & Investment Income
1.995.823.55.183.31
Currency Exchange Gain (Loss)
16.33-7.825.134.02-2.9
Other Non Operating Income (Expenses)
10.7627.3921.9820.7523.71
EBT Excluding Unusual Items
-26.58-33.24-76.97-77.74-107.2
Impairment of Goodwill
-111.54----46.36
Gain (Loss) on Sale of Investments
----15.24
Gain (Loss) on Sale of Assets
-3.8-0.03109.77-1.950.23
Asset Writedown
-125.56-19.94-5.54--
Other Unusual Items
-187.25-44.77-71.18-38.133.63
Pretax Income
-454.73-97.98-43.92-117.74-54.47
Income Tax Expense
27.831.0417.2-7.991.83
Earnings From Continuing Operations
-482.56-99.02-61.12-109.74-56.3
Earnings From Discontinued Operations
---43.3332.67
Net Income to Company
-482.56-99.02-61.12-66.41-23.63
Minority Interest in Earnings
54.7123.4832.2724.878.58
Net Income
-427.85-75.54-28.84-41.55-15.05
Net Income to Common
-427.85-75.54-28.84-41.55-15.05
Shares Outstanding (Basic)
5,5795,5795,5795,5795,579
Shares Outstanding (Diluted)
5,5795,5795,5795,5795,579
EPS (Basic)
-0.08-0.01-0.01-0.01-0.00
EPS (Diluted)
-0.08-0.01-0.01-0.01-0.00
Free Cash Flow
-33.4113.2-53.847.88
Free Cash Flow Per Share
-0.010.00-0.010.00
Gross Margin
56.15%57.51%58.25%56.62%49.32%
Operating Margin
-4.91%-5.04%-11.41%-9.44%-12.16%
Profit Margin
-46.77%-8.42%-3.56%-4.65%-1.87%
Free Cash Flow Margin
-3.72%1.63%-6.02%0.98%
EBITDA
-10.67-11-49.83-30.21-40
EBITDA Margin
-1.17%-1.23%-6.16%-3.38%-4.98%
D&A For EBITDA
34.2334.2342.4954.1957.71
EBIT
-44.9-45.23-92.33-84.41-97.71
EBIT Margin
-4.91%-5.04%-11.41%-9.44%-12.16%
Advertising Expenses
446.46427.6419.1428.68313.18
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.